Categories

Volume 5 Issue 8 (August, 2017)

Original Articles

A comparative assessment of topical olopatadine (0.1%) and alcaftadine (0.25%) in cases of allergic conjunctivitis
Dr. Garima Agarwal

Background: Ocular allergy is a commonly encountered pathology in clinical practice, with an increase in number of patients noticed in the last decade. The present study compared topical olopatadine (0.1%) and alcaftadine (0.25%) in cases of allergic conjunctivitis. Materials & Methods: 94 patients diagnosed with allergic conjunctivitis of both genders were randomly classified into 2 groups of 47 each. Group I patients were prescribed topical 0.1% Olopatadine eyedrops BID and group II patients were prescribed topical 0.25% Alcafatadine eye drops BID. Itching, redness, discharge and foreign body sensation were recorded. Results: At 15 minutes, 1 day and 1 week 10 patients in group I and 22 in group II, 35 in group I and 38 in group II and 47 in group I and II recovered from redness. At 15 minutes, 1 day and 1 week, 1 patient in group I and 2 in group II, 36 in group I and 38 in group II and 47 in group I and II recovered from discharge. At 15 minutes, 1 day and 1 week, 2 patients in group I and 3 in group II, 40 in group I and 38 in group II and 47 in group I and II recovered foreign body sensation. The difference was non- significant (P> 0.05). Conclusion: Both drugs found to be equally effective in cases of allergic conjunctivitis. Key words: Allergic conjunctivitis, Alcaftadine, Olopatadine.

 
Abstract View | Download PDF | Current Issue